Patent Eligibility Bill May Carve Out Patenting Of Research
Executive Summary
Witnesses at US Senate hearings debate bill's impact on drug pricing; discuss limiting it to medical diagnostics.
You may also be interested in...
Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress
Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. Industry groups criticize the proposals.
Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress
Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. PhRMA, BIO, AAM criticize the proposals.
Biopharma Dismayed US Supreme Court Declines To Take Up Case On Patent Eligibility
The Court denies a petition for review of American Axle and Manufacturing v. Neapco despite requests from the US government, BIO and former PTO director Kappos that it take up the case to provide greater clarity on the types of inventions that may be patented.